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An 80-year-old woman,  who had been administered α-glucosidase inhibitor for diabetes,  was brought 
to the hospital with the sensation of abdominal fullness and pain.  Abdominal computed tomography 
indicated pneumatosis cystoides intestinalis (PCI) in the small intestinal wall,  with free air within the 
abdomen.  A blood examination showed no increases in white blood cells or C-reactive protein level.  
The patientʼs condition improved with conservative therapy.  PCI with pneumoperitoneum induced by 
α-glucosidase inhibitor is rare,  with only 27 cases (excluding the present case) reported in Japan to 
date.  In PCI with pneumoperitoneum,  diﬀerentiation from gastrointestinal perforation is important 
and following the clinical symptoms over time is vital.
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neumatosis cystoides intestinalis (PCI) is a 
relatively rare disorder in which multilocular or 
linear air cysts form in the subserosa or submucosa of 
the intestinal tract wall [1].  The cause of PCI is 
unknown,  but the case of some individuals with this 
disorder that may have been induced by alpha 
(α)-glucosidase inhibitors have been reported in recent 
years [2-30].  We encountered a patient who had been 
administered α-glucosidase inhibitor and developed 
PCI with pneumoperitoneum.  This case was success-
fully cured with conservative treatment,  and we report 
our ﬁndings herein.
Case Report
　 An 80-year-old woman complained of feelings of 
abdominal bloating and abdominal pain while at an 
elder daycare facility and visited her previous doctor.  
Plain radiography of the abdomen showed free air,  and 
since peritonitis was therefore suspected,  she was 
brought to our hospital by ambulance.  She had no 
history of heavy alcohol intake or smoking,  and no 
family history of note.  She had undergone cholecys-
tectomy for cholelithiasis at 38 years of age.  At 71 
years of age,  she underwent hysterectomy for uterine 
cancer and received radiotherapy as adjuvant therapy.  
At 58 years of age,  she became paralyzed on the right 
side of the body following a cerebral infarction.  She 
was taking an α-glucosidase inhibitor for diabetes.  
There were no complications relevant to diabetes in 
this case.  In addition,  she was routinely taking mag-
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nesium oxide and purgatives for chronic constipation,  
along with oral medications such as antihypertensive 
agents.  When she was admitted to our hospital,  she 
had abdominal bloating and subcutaneous emphysema.  
Only mild tenderness was observed on palpation of the 
abdomen,  with no muscular guarding or rebound ten-
derness.  The results of physical examination on 
admission were as follows: body height,  138cm;  
body weight,  43kg; blood pressure,  204/91mmHg;  
body temperature,  36.8℃; heart rate,  69beats/min;  
respiratory rate,  18breaths/min; and peripheral oxygen 
saturation,  95ｵ.  The patient underwent blood testing 
and various imaging modalities.  No ﬁndings indicative 
of marked inﬂammatory reactions were observed from 
the results of complete blood count or blood biochem-
istry (Table 1).  Abdominal radiography showed dis-
tension of the intestine and an extraintestinal gas 
image,  suggesting pneumoperitoneum (Fig.  1).  Abdominal 
computed tomography (CT) revealed intraperitoneal 
free air and a gas image in the intestinal tract wall 
(Fig.  2A-C).
　 Based on the above ﬁndings,  PCI with pneumo-
peritoneum was diagnosed.  Concerning the pathologi-
cal conditions that present with intraperitoneal free 
air,  many types of perforations were considered as 
diﬀerential diagnoses,  including perforation of gastro-
intestinal ulcerations or tumors,  perforation of a 
diverticulum of the intestine,  and gastrointestinal 
perforation triggered by radiotherapy for uterine 
cancer.  However,  based on the CT ﬁndings,  PCI was 
considered most likely.  Conservative treatment was 
selected,  because of the minor increase in inﬂamma-
tory reaction and mild abdominal pain.  The patient 
was immediately hospitalized and monitoring was 
started with the administration of transfusion and 
antibiotics while the patient fasted.  We used cefmeta-
zole sodium for this patient.  The administration of 
α-glucosidase inhibitor was discontinued.  Her general 
status remained stable and the symptom of abdominal 
bloating became less severe on the day after hospital-
ization,  along with the passage of ﬂatus.  On Day 2 
after hospitalization,  another abdominal CT was con-
ducted,  showing decreased gas (Fig.  2D).  Improve-
ment of PCI was conﬁrmed and led us to prohibit 
water intake for the patient.  Because her symptoms 
were stable following water intake,  dietary intake was 
started on Day 4.  No exacerbation of abdominal 
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Fig. 1　 Abdominal X-ray showing distension of the intestine and 
an extraintestinal gas image under suspicion of pneumoperitoneum.
Table 1　 Blood biochemical ﬁndings.  No ﬁndings indicating 
marked inﬂammatory reactions were observed from complete blood 
count or biochemical examination
WBC 6,010 /µl CK 79 mg/dl
RBC 434 10,000/µl UN 18 mg/dl
Hb 13.7 g/dl Cr 0.5 mg/dl
Ht 41.2 % UA 3 mg/dl
PLT 25 10,000/µl CRP 0.06 mg/dl
TP 7.1 g/dl Na 136 mEq/l
Alb 4.2 g/dl K 4.1 mEq/l
T-Bil 0.44 mg/dl Cl 104 mEq/l
AST 29 IU/l FBS 108 mg/dl
ALT 18 IU/l PT-INR 0.9
γGTP 19 IU/l APTT 28.3 Sec
LDH 279 IU/l D dimer 6.3 µg/ml
WBC,  white blood cell; RBC,  red blood cell count; Hb,  
hamoglobin; Ht,  hematocrit; PLT,  platelet; TP,  total protein; Alb,  
albumin; T-Bil,  total bilirubin; AST,  aspartate amino trans-
ferase; ALT,  alanine aminotransferase; γGTP,  gamma glutamyl 
transpeptidase; LDH,  lactic acid dehydrogenase; CK,  creatine 
phosphokinase; UN,  blood urea nitrogen; Cr,  creatinine; UA,  uric 
acid; CRP,  C reactive protein; Na,  Natrium; K,  potassium; Cl,  
chlorine; FBS,  fasting blood sugar; PT-INR,  prothrombin time 
international normalized ratio; APTT,  activated partial thrombo-
plastin time.
symptoms was observed thereafter and she was moved 
to the referring hospital on Day 6.
Discussion
　 With PCI,  multiple air cysts are formed in the 
submucosa or subserosa of the intestinal tract wall.  
Abdominal pain,  constipation,  and a feeling of 
abdominal bloating are representative symptoms.  
Various causes for the development of PCI have been 
considered,  and the following theories have been 
reported.  The ﬁrst option is that intestinal inner 
pressure increases,  causing intestinal gas to invade the 
inside of the intestinal tract wall through a damaged 
area of mucosa [31].  Second,  gas-producing bacteria 
such as Clostridium may pass through the intestinal 
tract wall and produce gas in the intestinal tract wall 
[32].  Third,  air leaks may occur through alveoli 
damaged due to a lung disorder,  reaching the intesti-
nal membrane or intestinal tract wall via the mediasti-
num/retroperitoneum,  and forming air bubbles [33].  
Fourth,  the condition may develop due to exposure to 
chemicals such as trichloroethylene [34].  In addition,  
in cases of collagen disease or with long-term adminis-
tration of steroids,  a weakened intestinal tract wall 
may be the cause [4,  9,  10,  12,  22,  23].  However,  
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Fig. 2　 Abdominal CT.  A,  Intraperitoneal free air is apparent on the surface of the liver in the upper abdominal area; B, C,  Gas image 
in the intestinal tract wall,  mainly in the small intestine; D,  On CT conducted 2 days after hospitalization,  the gas image shows a 
decreasing tendency.
in recent years,  some cases probably induced by 
α-glucosidase inhibitors,  as oral diabetes drugs,  have 
been reported.  These α-glucosidase inhibitors act to 
limit increases in blood sugar levels by inhibiting the 
degradation of disaccharide into saccharide,  thus 
inhibiting and delaying the absorption of glucide.  With 
this action,  glucide is not completely digested and 
reaches the inside of the large intestine from the lower 
small intestine.  Through this mechanism,  incompletely 
digested glucide remains present and promotes 
increases in intestinal bacteria and fragmentation by 
enzymes of these bacteria,  yielding organic acids such 
as lactic acid and butyric acid,  along with intestinal 
gases such as hydrogen gas and methane gas.  Due to 
the increased presence of gas in the intestine,  side 
eﬀects of α-glucosidase inhibitors include abdominal 
bloating and ﬂatulence.  Taniyama et al.  suggested that 
the associated increase in internal pressure in the 
intestine contributes to PCI [35].  Excluding the 
present patient,  27 case reports of PCI induced by 
α-glucosidase inhibitors in Japan and 2 cases in other 
country were identiﬁed using the keywords “pneuma-
tosis cystoids intestinalis” and “α-glucosidase inhibi-
tor” or “pneumatosis cystoids intestinalis” and “diabe-
tes mellitus” in a search of the Japan Centra Evuo 
Medicina and Pubmed (Table 2).  The range of age of 
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Table 2　 Reported cases of Pneumatosis cystoides intestinalis in patients internally administered α-glucosidase inhibitor
Age Gender Major complaints Surgery Outcome Person who reported the case/year
1 87 Female Abdominal bloating × Remission Azami [2] 2000
2 73 Female Abdominal bloating × Remission Tachibana [3] 2002
3 55 Female Abdominal bloating × Remission Maeda [4] 2002
4 73 Female Abdominal pain Peritoneal washing, drainage Remission Matsuda [5] 2004
5 unknown Female Abdominal pain × Remission Furio [6] 2006
6 65 Male Abdominal pain/Diarrhea × Remission Miyakawa [7] 2006
7 66 Male Abdominal bloating × Remission Nagahara [8] 2006
8 56 Female Abdominal bloating × Remission Hisamoto [9] 2006
9 77 Female Abdominal pain Exploratory laparotomy Remission Maeda [10] 2007
10 75 Male Abdominal bloating × Remission Yasuoka [11] 2007
11 69 Male Abdominal pain × Remission Tsujimoto [12] 2008
12 58 Male Nothing in particular × Remission Hosoi [13] 2008
13 79 Female Abdominal bloating × Remission Kinuta [14] 2008
14 65 Female Abdominal pain × Remission Vogel [15] 2008
15 71 Female Abdominal pain/Vomiting Exploratory laparotomy Remission Gondo [16] 2009
16 73 Female Abdominal bloating/Abdominal pain Exploratory laparotomy Remission Kuwada [17] 2010
17 60 Male Abdominal bloating/Abdominal pain × Remission Kusano [18] 2010
18 88 Male Abdominal bloating Exploratory laparotomy Remission Kasumoto [19] 2010
19 58 Male Abdominal pain × Remission Kojima [20] 2010
20 91 Male Abdominal pain/Vomiting × Remission Misuta [21] 2010
21 48 Male Nothing in particular × Remission Shimojima [22] 2011
22 68 Male Nothing in particular × Remission Igata [23] 2011
23 89 Female Abdominal pain Exploratory laparoscopy Remission Matsuda [24] 2011
24 67 Female Abdominal pain Exploratory laparotomy Remission Ishioka [25] 2011
25 66 Male Nothing in particular × Remission Nakaji [26] 2011
26 80 Female Abdominal bloating × Remission Shigetoshi [27] 2011
27 70 Male Abdominal bloating × Remission Matsuura [28] 2011
28 76 Male Abdominal pain × Remission Hashimoto [29] 2011
29 67 Male Abdominal bloating/Abdominal pain × Remission Miyamoto [30] 2012
30 80 Female Abdominal bloating/Abdominal pain × Remission Our case 2013
the patients was 48 to 91 years old (average,  70.6 
years).  Three patients had a renal disease,  2 patients 
had a collagen disease,  2 patients had a pemphigus,  
and 1 patient had a myasthenia gravis.  Six of the 
patients had received long-term steroid treatment.  
Among the above theories regarding PCI develop-
ment,  the administration of α-glucosidase inhibitors 
applies to the present case.  In addition,  internal pres-
sure in the abdomen would have been increased physi-
ologically due to chronic constipation and decreased 
vermiculation from diabetes.  As treatment,  conserva-
tive management can be used for PCI if the internal 
administration of α-glucosidase inhibitor is discontin-
ued and symptoms recover with fasting.  Oxygen 
therapy is also reportedly eﬀective [5,  6,  8,  11,  17,  
23,  26,  28].  In terms of the underlying mechanism,  
gas in the intestinal tract wall in PCI is normally 
thought to be nitrogen gas,  and the administered 
oxygen generates a denitrogenation action [36].  
However,  in cases with pneumoperitoneum like the 
present case,  diﬀerential diagnosis from gastrointes-
tinal perforation is important,  as mentioned above.  
When clinical symptoms progress,  operative therapy 
should be considered and the patient should be moni-
tored carefully.
　 In conclusion,  We encountered a successfully treated 
case of PCI with pneumoperitoneum.  An α-glucosi-
dase inhibitor was considered one of the main patho-
genic factors in this case of PCI.  In PCI with pneu-
moperitoneum,  diﬀerentiation from gastrointestinal 
perforation is quite important,  and the strict follow-up 
of clinical symptoms over time is vital.
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